What did ophthalmologists read on Medscape during 2011? We looked back to find out and compiled a list of the most popular articles for this year.
For ophthalmologists, it seemed to boil down to money, Medicare, malpractice, and medicine, although not necessarily in that order. With the still struggling economy and the continuing threat of declining reimbursements, it is not surprising that articles pertaining to money and Medicare were popular. Also not surprising is that any news surrounding Avastin® (bevacizumab) and Lucentis® (ranibizumab) in the treatment of neovascular ("wet") age-related macular degeneration continue to resonate with readers. The year brought bright spots too, with exciting innovations in technology and ongoing developments in treatment, including the use of the femtosecond laser for cataract surgery, the advance of corneal collagen cross-linking for keratoconus, and the promise of novel drug delivery systems for glaucoma.
The most popular articles, as determined by how many of our members chose to read them, are provided below. If you missed these important articles, please take a minute to review them and see what your colleagues are reading.
4. Avastin (bevacizumab) and Lucentis (ranibizumab)
3. Medicare and the sustainable growth rate
2. Money and the business of medicine
And the number one most-read article by ophthalmologists on Medscape in 2011 was...
Medscape Ophthalmology © 2011 WebMD, LLC
Cite this: Lauri R. Graham. Top 10 for 2011: Most-Read Ophthalmology Articles - Medscape - Dec 08, 2011.